Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBC.1.6.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JB.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.7.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.30.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.68SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.122.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBTSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBMSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.55SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HH.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.7.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.123.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.9.2.2 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.272SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.371SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.353SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.407SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.47SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.182SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.218SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.12.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used